Related Experiment Video
Updated: May 10, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Severe meningococcal infection: a review of epidemiology, diagnosis, and management
Paul A Campsall1, Kevin B Laupland, Daniel J Niven
1Department of Critical Care Medicine, University of Calgary and Alberta Health Services, 3500 26th Avenue Northeast, Calgary, Alberta T1Y 6J4, Canada.
Abstract:
Neisseria meningitidis, also known as meningococcus, is a relatively uncommon cause of invasive infection, but when it occurs it is frequently severe and potentially life threatening. Meningococcus should be considered and investigated promptly as a potentially etiologic pathogen in any patient with meningitis, or sepsis accompanied by a petechial rash. Suspected patients should receive early appropriate antimicrobial therapy concomitantly with confirmatory invasive diagnostic tests. Vaccines have reduced the incidence of infection with certain non-B meningococcal serogroups, and new serotype B vaccines are on the horizon. This article reviews the epidemiology, diagnosis, and management of severe meningococcal infections.
Insights
Neisseria meningitidis (meningococcus) causes rare but severe infections like meningitis and sepsis. Prompt diagnosis, antimicrobial therapy, and vaccines are key to managing meningococcal disease.
Area of Science:
- Microbiology
- Infectious Diseases
- Vaccinology
Background:
- Neisseria meningitidis (meningococcus) is a significant cause of invasive bacterial infections.
- Meningococcal infections, though uncommon, are frequently severe and life-threatening, presenting as meningitis or sepsis with a petechial rash.
Purpose of the Study:
- To review the epidemiology, diagnosis, and management of severe Neisseria meningitidis infections.
- To highlight the importance of prompt recognition and treatment of meningococcal disease.
Main Methods:
- Literature review of Neisseria meningitidis epidemiology.
- Analysis of diagnostic approaches for meningococcal infections.
- Review of current and emerging therapeutic strategies, including vaccines.
Main Results:
- Neisseria meningitidis requires prompt consideration in patients with meningitis or sepsis and a petechial rash.
- Early antimicrobial therapy and invasive diagnostic tests are crucial for suspected cases.
- Vaccines have decreased the incidence of certain serogroups, with new serotype B vaccines anticipated.
Conclusions:
- Early and appropriate management is critical for improving outcomes in severe meningococcal infections.
- Vaccination remains a vital tool in controlling meningococcal disease, with ongoing vaccine development.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management

